July 5, 2023 07:05 AM EDT

FDA rejects Amneal's extended-release Parkinson's treatment, seeking more safety data

Amber Tong

The FDA has rejected specialty pharma and generics maker Amneal Pharmaceuticals’ extended-release capsule for Parkinson’s disease, which combines two drugs that have long been used …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

FDA rejects Amneal's extended-release Parkinson's treatment, seeking more safety data

Amber Tong

Sign up to read this article for free.

Trump team asked Warp Speed leader to head NIH, may seek more traditional pick for role

How did Trump’s FDA pick land? Biotech stocks are up, and executives are (mostly) relieved

Bristol Myers reveals more job cuts in New Jersey

Merck halts Phase 3 trial with PAH drug Winrevair following positive interim data

Gilead buys experimental HIV vaccines from a small Barcelona biotech

Incyte touts Monjuvi data from Phase 3 follicular lymphoma trial as it heads to FDA

FDA re­jects Am­neal's ex­tend­ed-re­lease Parkin­son's treat­ment, seek­ing more safe­ty da­ta

Amber Tong

Sign up to read this article for free.

more like this

Trump team asked Warp Speed leader to head NIH, may seek more tra­di­tion­al pick for role

How did Trump’s FDA pick land? Biotech stocks are up, and ex­ec­u­tives are (most­ly) re­lieved

Bris­tol My­ers re­veals more job cuts in New Jer­sey

Mer­ck halts Phase 3 tri­al with PAH drug Win­re­vair fol­low­ing pos­i­tive in­ter­im da­ta

Gilead buys ex­per­i­men­tal HIV vac­cines from a small Barcelona biotech

In­cyte touts Mon­ju­vi da­ta from Phase 3 fol­lic­u­lar lym­phoma tri­al as it heads to FDA

FDA rejects Amneal's extended-release Parkinson's treatment, seeking more safety data

Trump team asked Warp Speed leader to head NIH, may seek more traditional pick for role

How did Trump’s FDA pick land? Biotech stocks are up, and executives are (mostly) relieved

Bristol Myers reveals more job cuts in New Jersey

Merck halts Phase 3 trial with PAH drug Winrevair following positive interim data

Gilead buys experimental HIV vaccines from a small Barcelona biotech

Incyte touts Monjuvi data from Phase 3 follicular lymphoma trial as it heads to FDA